High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques-Reference-Cited by-同舟云学术

High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques

Published:1996-12 Issue:1-2 Volume:144 Page:182-190
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Simone Isabella Laura,Federico Francesco,Trojano Maria,Tortorella Carla,Liguori Maria,Giannini Paolo,Picciola Emilia,Natile Giovanni,Livrea Paolo

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference39 articles.

1. Adams, C.W.M. (1983) The general pathology of multiple sclerosis: Morphological and chemical aspects of the lesions. In: Hallpike, J.F., Adams, C.W.M., Tourtellotte, W.W. (Eds.), Multiple Sclerosis. Pathology, Diagnosis and Management, Williams and Wilkins, Baltimore, pp. 203–240.

2. Clinical neurochemistry for diagnosis in multiple sclerosis: European Consensus;Andersson;J. Neurol. Neurosurg. Psychiatry,1994

3. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques;Arnold;Ann. Neurol.,1992

4. Cerebrospinal fluid choline in extrapiramidal disorders;Aquilonius;J. Neurol. Neurosurg. Psychiatry,1972

5. Assessment of current diagnostic criteria for Guillain-Barré syndrome;Asbury;Ann. Neurol.,1990

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detecting macromolecular differences of the CSF in low disability multiple sclerosis using quantitative MT MRI at 3T;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2023-10

2. Implications of immunometabolism for smouldering MS pathology and therapy;Nature Reviews Neurology;2023-07-10

3. Association of multiple sclerosis with chronic fatigue syndrome, restless legs syndrome, and various sleep disorders, along with the recent updates;Annals of Medicine & Surgery;2023-05-26

4. Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis;Frontiers in Genetics;2023-01-30

5. Metabolomics in Autoimmunity, Infections, and Physiological Diseases;Metabolomics;2023